Congresswoman Katie Porter dismantles the argument that high drug prices help fund research and development for new and better drugs. “It’s true that pharmaceutical companies spend money on research and development, but it is not correct that that is the primary reason that they double, and triple and quadruple raising the prices of these drugs - it’s to profit their shareholders,” she says.